The industry has long struggled with its failure to diversify clinical trials but 2020’s defining events — COVID-19 and social-justice protests — made it even more urgent. This compelling campaign generated more than 17 million impressions, steering people to a petition on to demand improvement in inclusion criteria. Judges love the “spot-on copy and beautiful execution,” as well as its “real power to save lives.”